Prospectively Collected Pleural Biopsies for Validation of Malignant Pleural Mesothelioma Prognostic Biomarkers

Description

This research study is evaluating a new method for determining stage and prognosis of individuals with malignant pleural mesothelioma.

Conditions

Mesothelioma

Talk to us

Study Overview

On this page

Study Details

Study overview

This research study is evaluating a new method for determining stage and prognosis of individuals with malignant pleural mesothelioma.

Prospectively Collected Pleural Biopsies for Validation of Malignant Pleural Mesothelioma Prognostic Biomarkers

Prospectively Collected Pleural Biopsies for Validation of Malignant Pleural Mesothelioma Prognostic Biomarkers

Condition
Mesothelioma
Intervention / Treatment

-

Contacts and Locations

Boston

Brigham and Women's Hospital, Boston, Massachusetts, United States, 02215

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * All adult patients with a diagnosis of malignant pleural mesothelioma undergoing
  • * diagnostic pleural biopsy
  • * pleuroscopy
  • * and/or VATS resections
  • * Participants must be 18 years of age or older.
  • * surgery,
  • * treatment
  • * diagnosis,

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Dana-Farber Cancer Institute,

Raphael Bueno, MD, PRINCIPAL_INVESTIGATOR, Brigham and Women's Hospital

Study Record Dates

2025-10-01